StockData
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.01−0.09 (-8.18%)

Close on Nov 17, 2026Market cap $13.47MP/E –Yield 0.00%

Earnings

Tvardi Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 30, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.48
-$0.59 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Tvardi Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 30, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026before the open––-$0.48Release
Q2 FY2026ended Jun 30, 2026Aug 14, 2026before the open––-$0.69Release
Q1 FY2026ended Mar 31, 2026May 8, 2026before the open––-$0.73Release
Q4 FY2025ended Dec 31, 2025Mar 31, 2026during market hours––-$0.78Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025during market hours––-$0.59Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025during market hours–––Release
Q1 FY2025ended Mar 31, 2025May 13, 2025during market hours–––Release
Q1 FY2024ended Mar 31, 2024May 13, 2024during market hours$2.10M-66.1%-$0.56Release
Q4 FY2023ended Dec 31, 2023Mar 4, 2024during market hours$3.00M-9.1%-$0.59Release
Q3 FY2023ended Sep 30, 2023Nov 13, 2023during market hours$4.90M-54.6%-$0.52Release
Q2 FY2023ended Jun 30, 2023Aug 7, 2023during market hours$6.90M-70.0%-$0.58Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Tvardi Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Tvardi Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Tvardi Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Update
  5. Update
  6. Update
  7. Results
  8. Results
  9. Update
  10. Update
  11. Results
  12. News
  13. Results
  14. News
  15. Update

See a number that looks wrong?